Article
Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients.
European journal of clinical pharmacology - 1 Nov 2008
Qiu Xiao-Yan, Jiao Zheng, Zhang Ming, Zhong Long-Jin, Liang Hui-Qi, Ma Chun-Lai, Zhang Liang, Zhong Ming-Kang
Abstract excerpt
OBJECTIVE: The objective of this study was to retrospectively evaluate the effects of MDR1, CYP3A4*18B, and CYP3A5*3 genetic polymorphisms on cyclosporine A (CsA) pharmacokinetics in Chinese renal transplant patients during the first month after transplantation. METHODS: A total of 103 renal transplant recipients receiving CsA were genotyped for MDR1 (C1236T, G2677T/A, and C3435T), CYP3A4*18B, and CYP3A5*3. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
